@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms

NCT05526352 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2026-01-16

No results posted yet for this study

Summary

The primary aim of the SwissNeuroFoundation AneurysmDataBase Project is to implement information technology based tools to create and use a holistic reference database specific to intracranial aneurysms (IA).

The SwissNeuroFoundation AneurysmDataBase are concerned with generating the data with which to populate this database.

The purpose for populating the database are to:

* Screen for and evaluate markers of risk for intracranial aneurysm formation and aneurysm rupture. Are considered as markers the following: genetics factors, microbiota, environmental factors, congenital factors (ie: cerebrovascular anatomical variants), transcriptomics signature, proteomics signature,shape characteristics, haemodynamics characteristics.
* Screen for and evaluate prognostic factors of outcome regarding different management strategies including watchful observation, microsurgical treatment, endovascular treatment or any combination thereof.
* Implement and evaluate patient-specific management protocols integrating all available information.
* Evaluate the impact of the database and use of tools to improve care, reduce costs, support knowledge discovery and promote new industrial developments.

Conditions

  • Intracranial Aneurysm

Sponsors & Collaborators

  • University of Geneva, Switzerland

    collaborator OTHER
  • Klinik Hirslanden, Zurich

    collaborator OTHER
  • University Hospital, Geneva

    lead OTHER

Principal Investigators

  • Philippe Bijlenga, PD MD PhD · Geneva University

  • Sandrine Morel, PD PhD · Hôpitaux Universitaire de Genève

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-01
Primary Completion
2040-03-01
Completion
2040-03-01

Countries

  • United States
  • Canada
  • Finland
  • France
  • Germany
  • Hungary
  • Netherlands
  • Poland
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05526352 on ClinicalTrials.gov